Venlafaxine 100mg Tablets

Manufacturer ZYDUS PHARMACEUTICALS (USA) Active Ingredient Venlafaxine Tablets(ven la FAX een) Pronunciation ven-la-FAX-een
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Antidepressant
🧬
Pharmacologic Class
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Dec 1993
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Venlafaxine is a medication used to treat depression and anxiety disorders. It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain, which can improve mood and feelings of well-being.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow these steps:

Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
Take your medication with food to help your body absorb it properly.
Establish a routine by taking your medication at the same time every day.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel better.

Storing and Disposing of Your Medication

To ensure your medication remains effective and safe:

Store your medication at room temperature in a dry place, away from the bathroom.
Keep all medications in a secure location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist or healthcare provider.
Check with your pharmacist for guidance on the best way to dispose of your medication. You may also have access to drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose of your medication:

Take the missed dose as soon as you remember.
If it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
Do not take two doses at the same time or take extra doses to make up for a missed dose.
πŸ’‘

Lifestyle & Tips

  • Take exactly as prescribed, do not stop suddenly without consulting your doctor, as this can cause withdrawal symptoms.
  • Avoid alcohol, as it can worsen side effects.
  • Be cautious when driving or operating machinery until you know how this medication affects you, as it can cause dizziness or drowsiness.
  • Report any unusual changes in mood or behavior, especially suicidal thoughts, to your doctor immediately.
  • Inform your doctor and pharmacist about all other medications, supplements, and herbal products you are taking to avoid dangerous interactions, especially St. John's Wort or other antidepressants.
  • Monitor blood pressure regularly as advised by your doctor.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 100 mg orally per day, divided into 2 or 3 doses. Typically initiated at 37.5 mg or 75 mg/day and titrated.
Dose Range: 75 - 375 mg

Condition-Specific Dosing:

Major Depressive Disorder (MDD): Initial: 75 mg/day in 2-3 divided doses. May increase by 75 mg/day increments at intervals of no less than 4 days, up to 375 mg/day for severe depression. For 100mg tablets, this would typically be 50mg BID or 100mg QD if tolerated, but usually divided doses for IR.
Generalized Anxiety Disorder (GAD): Not typically used for GAD with immediate release. Extended-release (XR) is 75-225 mg/day.
Social Anxiety Disorder (SAD): Not typically used for SAD with immediate release. Extended-release (XR) is 75 mg/day.
Panic Disorder: Not typically used for Panic Disorder with immediate release. Extended-release (XR) is 75 mg/day.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established (Safety and efficacy not established in pediatric patients <18 years of age for MDD, GAD, SAD, Panic Disorder).
Adolescent: Not established (Safety and efficacy not established in pediatric patients <18 years of age for MDD, GAD, SAD, Panic Disorder).
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment needed for mild to moderate impairment (CrCl 30-90 mL/min).
Moderate: Reduce total daily dose by 25-50% (CrCl 10-29 mL/min).
Severe: Reduce total daily dose by 50% or more (CrCl <10 mL/min).
Dialysis: Reduce total daily dose by 50% and withhold dose until after dialysis session (hemodialysis patients).

Hepatic Impairment:

Mild: Reduce total daily dose by 50% (Child-Pugh A).
Moderate: Reduce total daily dose by 50% (Child-Pugh B).
Severe: Reduce total daily dose by 50% or more (Child-Pugh C).

Pharmacology

πŸ”¬

Mechanism of Action

Venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are potent inhibitors of neuronal serotonin and norepinephrine reuptake and a weak inhibitor of dopamine reuptake. This leads to increased concentrations of these neurotransmitters in the synaptic cleft, enhancing their activity in the central nervous system.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 45% (due to presystemic metabolism)
Tmax: Venlafaxine: 2 hours (IR); ODV: 3 hours (IR)
FoodEffect: Food has no significant effect on the absorption or peak concentration of venlafaxine or ODV.

Distribution:

Vd: Venlafaxine: 7.5 L/kg; ODV: 5.7 L/kg
ProteinBinding: Venlafaxine: Approximately 27%; ODV: Approximately 30%
CnssPenetration: Yes

Elimination:

HalfLife: Venlafaxine: Approximately 5 hours; ODV: Approximately 11 hours
Clearance: Venlafaxine: 1.3 Β± 0.6 L/h/kg; ODV: 0.4 Β± 0.2 L/h/kg
ExcretionRoute: Renal (approximately 87% of a dose is excreted in the urine within 48 hours as unchanged venlafaxine, ODV, or other metabolites)
Unchanged: Approximately 5% (venlafaxine); Approximately 29% (ODV)
⏱️

Pharmacodynamics

OnsetOfAction: Initial antidepressant effects may be seen within 1-2 weeks, but full therapeutic effects may take 4-6 weeks.
PeakEffect: Not precisely defined for clinical effect, but steady-state plasma concentrations are typically achieved within 3 days for venlafaxine and 4-5 days for ODV with multiple dosing.
DurationOfAction: Sustained as long as medication is taken; discontinuation leads to withdrawal symptoms due to short half-life.

Safety & Warnings

⚠️

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of venlafaxine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of low sodium levels, including:
+ Headache
+ Trouble focusing or memory problems
+ Feeling confused or weak
+ Seizures or changes in balance
Signs of bleeding, such as:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding from the gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that enlarge
+ Uncontrollable bleeding
Signs of high blood pressure, including:
+ Severe headache or dizziness
+ Fainting or changes in vision
Seizures
Chest pain or pressure
Shortness of breath
Cough
Bone pain
Sexual problems, such as:
+ Decreased interest in sex
+ Difficulty having an orgasm
+ Ejaculation problems
+ Trouble getting or maintaining an erection
A potentially life-threatening condition called serotonin syndrome, which may be more likely if you take certain other medications. Seek medical help immediately if you experience:
+ Agitation
+ Changes in balance
+ Confusion
+ Hallucinations
+ Fever
+ Rapid or abnormal heartbeat
+ Flushing
+ Muscle twitching or stiffness
+ Seizures
+ Shivering or shaking
+ Excessive sweating
+ Severe diarrhea, stomach upset, or vomiting
+ Severe headache

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only mild ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or persist, contact your doctor:

Difficulty sleeping
Feeling nervous, anxious, or excitable
Weight loss
Dizziness, drowsiness, tiredness, or weakness
Shakiness
Headache
Excessive sweating
Constipation, diarrhea, stomach upset, vomiting, or decreased appetite
Gas
Dry mouth
Strange or unusual dreams
* Yawning

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or anxiety
  • New or worsening thoughts of self-harm or suicide
  • Unusual changes in behavior (e.g., agitation, restlessness, panic attacks, irritability, aggression, impulsivity, severe insomnia, hypomania, mania)
  • Symptoms of serotonin syndrome: confusion, hallucinations, rapid heart rate, sweating, muscle stiffness or twitching, fever, nausea, vomiting, diarrhea.
  • Severe allergic reaction (rash, itching/swelling, severe dizziness, trouble breathing)
  • Eye pain, vision changes, or swelling/redness around the eye (signs of angle-closure glaucoma)
  • Unexplained bleeding or bruising
  • Seizures
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions and situations to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
If you have high blood pressure, as this may be relevant to your treatment.
If you have narrow-angle glaucoma, a condition that affects the eyes.
If you are currently taking a weight loss medication, as this may interact with the prescribed drug.
If you are taking or have recently taken certain medications, including:
+ Linezolid or methylene blue, as these can interact with the prescribed medication.
+ Certain drugs for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, within the last 14 days. Taking these medications together can lead to very high blood pressure.
Other health problems or medications that may interact with the prescribed drug, including prescription and over-the-counter medications, natural products, and vitamins.

To ensure your safety, it is crucial to provide your doctor and pharmacist with a comprehensive list of all your medications and health problems. This will help them determine whether it is safe for you to take this medication with your other treatments. Never start, stop, or change the dose of any medication without consulting your doctor first.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This will help ensure your safety and prevent any potential interactions with other treatments.

Until you know how this medication affects you, avoid driving and other activities that require you to be alert. This is crucial to prevent accidents and ensure your safety.

Do not stop taking this medication abruptly without consulting your doctor, as this may increase your risk of side effects. In some cases, these side effects can be severe and long-lasting. If you need to discontinue this medication, your doctor will guide you on how to gradually stop taking it. Be sure to discuss any new or worsening symptoms with your doctor.

Regular blood pressure checks are necessary while taking this medication, as it may cause high blood pressure. Your doctor will advise you on the frequency of these checks.

It is recommended to avoid consuming alcohol while taking this medication. Additionally, consult your doctor before using marijuana, cannabis, or any prescription or over-the-counter medications that may cause drowsiness.

This medication may increase the risk of bleeding, which can be life-threatening in some cases. Discuss this risk with your doctor, especially if you have any concerns.

If you have bipolar disorder, be aware that this medication may trigger manic episodes. Contact your doctor immediately if you experience any symptoms of a manic episode.

Some individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess this risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, seek medical attention promptly.

Low blood sodium levels (hyponatremia) can occur with this medication, and in severe cases, it can be fatal. Discuss this risk with your doctor and report any concerns.

High cholesterol has been reported in some individuals taking this medication. If you have questions or concerns, consult your doctor.

This medication may affect certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this medication to ensure accurate test results.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

In children and adolescents, this medication may affect growth in some cases. Regular growth checks may be necessary, and your doctor will discuss this with you.

If you are pregnant, plan to become pregnant, or are breastfeeding, consult your doctor to discuss the benefits and risks of taking this medication. Taking this medication in mid to late pregnancy may lead to health problems in the mother (such as postpartum bleeding) or the newborn. Your doctor will help you weigh the risks and benefits and make an informed decision.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Somnolence
  • Mild to moderate increase in heart rate
  • Blood pressure changes (increase or decrease)
  • Dilated pupils
  • Nausea
  • Vomiting
  • Dizziness
  • Seizures
  • Electrocardiogram (ECG) changes (e.g., QTc prolongation, bundle branch block, QRS prolongation)
  • Coma
  • Serotonin syndrome

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Management is supportive and symptomatic; there is no specific antidote.

Drug Interactions

🚫

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) - risk of serious, sometimes fatal, serotonin syndrome. Must allow at least 14 days between discontinuing an MAOI and starting venlafaxine, and at least 7 days between discontinuing venlafaxine and starting an MAOI.
πŸ”΄

Major Interactions

  • Other serotonergic drugs (e.g., SSRIs, SNRIs, triptans, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's Wort) - increased risk of serotonin syndrome.
  • Drugs that impair metabolism of venlafaxine (e.g., strong CYP2D6 inhibitors like quinidine, fluoxetine, paroxetine) - may increase venlafaxine levels and decrease ODV levels, potentially altering efficacy/safety.
  • Drugs that increase bleeding risk (e.g., NSAIDs, aspirin, warfarin, other anticoagulants) - increased risk of abnormal bleeding due to venlafaxine's effect on serotonin uptake by platelets.
  • Linezolid (antibiotic with MAOI activity) - risk of serotonin syndrome.
  • Methylene blue (IV formulation) - risk of serotonin syndrome.
🟑

Moderate Interactions

  • Alcohol - may enhance CNS depressant effects and impair psychomotor skills.
  • Cimetidine - may inhibit first-pass metabolism of venlafaxine, increasing AUC.
  • Haloperidol - venlafaxine may increase haloperidol AUC and Cmax.
  • Metoprolol - venlafaxine may increase metoprolol plasma levels.
  • Indinavir - venlafaxine may decrease indinavir AUC and Cmax.
  • Drugs that prolong QT interval - theoretical risk, though venlafaxine's effect on QTc is generally small.
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Blood Pressure (BP)

Rationale: Venlafaxine can cause dose-dependent increases in blood pressure.

Timing: Prior to initiation of therapy.

Heart Rate

Rationale: Venlafaxine can cause increases in heart rate.

Timing: Prior to initiation of therapy.

Weight

Rationale: Changes in weight (gain or loss) can occur with antidepressant therapy.

Timing: Prior to initiation of therapy.

Mental Status/Suicidal Ideation

Rationale: Assess baseline mood, anxiety, and suicidal thoughts, especially in young adults and adolescents.

Timing: Prior to initiation of therapy.

Sodium (Na+)

Rationale: Risk of hyponatremia, especially in elderly or volume-depleted patients.

Timing: Consider in at-risk patients.

πŸ“Š

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly, especially during dose titration and periodically thereafter.

Target: Maintain within normal limits or patient's baseline.

Action Threshold: Significant or sustained elevation (e.g., >140/90 mmHg) may require dose reduction or discontinuation.

Heart Rate

Frequency: Periodically.

Target: Maintain within normal limits.

Action Threshold: Persistent tachycardia.

Weight

Frequency: Periodically.

Target: Maintain stable weight.

Action Threshold: Significant, unexplained weight gain or loss.

Mental Status/Suicidal Ideation

Frequency: Weekly during initial weeks of therapy and dose changes, then periodically.

Target: Improvement in mood/anxiety, absence of suicidal thoughts.

Action Threshold: Worsening depression, emergence of suicidal thoughts/behavior, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, akathisia, hypomania, mania.

Serotonin Syndrome Symptoms

Frequency: Ongoing, especially when co-administered with other serotonergic agents.

Target: Absence of symptoms.

Action Threshold: Agitation, hallucinations, delirium, coma, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, tremor, rigidity, myoclonus, hyperreflexia, incoordination, nausea, vomiting, diarrhea.

Bleeding/Bruising

Frequency: Ongoing, especially with concomitant use of anticoagulants/antiplatelets.

Target: Absence of abnormal bleeding.

Action Threshold: Unexplained bruising, petechiae, purpura, GI bleeding.

πŸ‘οΈ

Symptom Monitoring

  • Mood changes (improvement or worsening)
  • Anxiety levels
  • Sleep patterns (insomnia or somnolence)
  • Appetite changes
  • Energy levels
  • Agitation or restlessness
  • Irritability
  • Panic attacks
  • New or worsening suicidal thoughts or behaviors
  • Unusual changes in behavior
  • Headache
  • Nausea/vomiting
  • Dizziness
  • Dry mouth
  • Sweating
  • Sexual dysfunction
  • Symptoms of serotonin syndrome (e.g., confusion, rapid heart rate, muscle stiffness, sweating, fever)
  • Symptoms of discontinuation syndrome (e.g., dizziness, nausea, headache, paresthesias, anxiety, insomnia, tremor, flu-like symptoms)

Special Patient Groups

🀰

Pregnancy

Use during pregnancy should be considered only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to SNRIs late in the third trimester have developed complications requiring prolonged hospitalization, respiratory support, and tube feeding.

Trimester-Specific Risks:

First Trimester: Limited data, but some studies suggest a possible small increased risk of certain birth defects (e.g., cardiac) with first-trimester exposure to SSRIs/SNRIs, though data for venlafaxine specifically is less conclusive.
Second Trimester: Not available
Third Trimester: Risk of persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome (e.g., respiratory distress, feeding difficulties, irritability, tremor, hypotonia, constant crying).
🀱

Lactation

Venlafaxine and its active metabolite (ODV) are excreted into breast milk. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the mother’s clinical need for venlafaxine, and any potential adverse effects on the breastfed infant from venlafaxine or from the underlying maternal condition. Monitor infants for sedation, poor feeding, and poor weight gain.

Infant Risk: L3 (Moderate risk) - Monitor for adverse effects such as drowsiness, irritability, poor feeding, and weight loss. Some reports of adverse effects in infants.
πŸ‘Ά

Pediatric Use

Safety and efficacy have not been established in pediatric patients. Antidepressants, including venlafaxine, increase the risk of suicidal thoughts and behavior in children, adolescents, and young adults (see Black Box Warning). Use is generally not recommended.

πŸ‘΄

Geriatric Use

No overall differences in effectiveness or safety were observed between geriatric and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Elderly patients may be at increased risk for hyponatremia and falls. Use lower initial doses and titrate slowly. Monitor for adverse effects, especially blood pressure and hyponatremia.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Venlafaxine immediate-release (IR) requires multiple daily doses (2-3 times/day) due to its shorter half-life, which can lead to more pronounced withdrawal symptoms if doses are missed or discontinued abruptly. Extended-release (XR) is generally preferred for once-daily dosing and better tolerability.
  • Always titrate venlafaxine doses slowly to minimize side effects, especially nausea, dizziness, and blood pressure increases.
  • Monitor blood pressure regularly, as venlafaxine can cause dose-dependent hypertension, particularly at higher doses.
  • Be vigilant for symptoms of serotonin syndrome, especially when co-prescribing with other serotonergic agents.
  • Educate patients thoroughly about the importance of not stopping venlafaxine suddenly due to the risk of severe discontinuation syndrome (e.g., 'brain zaps', dizziness, nausea, anxiety).
  • Consider genetic testing for CYP2D6 poor metabolizers, as they may have higher venlafaxine levels and lower ODV levels, potentially affecting efficacy and side effects, though routine testing is not universally recommended.
πŸ”„

Alternative Therapies

  • Other SNRIs (e.g., Duloxetine, Desvenlafaxine, Levomilnacipran)
  • SSRIs (e.g., Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram)
  • Atypical antidepressants (e.g., Bupropion, Mirtazapine, Trazodone)
  • Tricyclic Antidepressants (TCAs) (e.g., Amitriptyline, Nortriptyline)
  • Monoamine Oxidase Inhibitors (MAOIs) (e.g., Phenelzine, Tranylcypromine, Selegiline)
  • Psychotherapy (e.g., Cognitive Behavioral Therapy - CBT)
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 for 30 tablets of generic 100mg IR. per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information. Please read this guide carefully and review it again whenever you receive a refill. If you have any questions or concerns about this medication, don't hesitate to consult with your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.